Browse by author
Lookup NU author(s): Dr R Neely
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2019 The Author(s)It has been brought to our attention that the wording of the German reimbursement criteria for apheresis is not clear in the above paper (Section 7. Management of patients with raised Lipoprotein(a), Subheading: Apheresis). This should read: “In Germany, Lp(a) levels exceeding 60 mg/dl and LDL-cholesterol in normal range along with progressive CVD has been approved as an indication for regular lipoprotein apheresis since 2008.”
Author(s): Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H
Publication type: Note
Publication status: Published
Journal: Atherosclerosis
Year: 2020
Volume: 296
Pages: 48-48
Print publication date: 01/03/2020
Online publication date: 01/02/2020
Acceptance date: 02/04/2016
ISSN (print): 0021-9150
ISSN (electronic): 1879-1484
Publisher: Elsevier Ireland Ltd
URL: https://doi.org/10.1016/j.atherosclerosis.2020.01.019
DOI: 10.1016/j.atherosclerosis.2020.01.019